Instem To Deliver SEND Education Course and Showcase Leading Software Solutions at Safety Pharmacology Society Conference, Berlin
18 Sep 2017

CROISSY SUR SEINE, Yvelines – September 18, 2017 - -Instem, a leading provider of IT solutions to the global early development healthcare market is pleased to announce it will be exhibiting and presenting at the 2017 Safety Pharmacology Society Annual Meeting, September 24–27, 2017, at the Maritim Hotel, Berlin, Germany.

NOTOCORD, an Instem company, will be exhibiting at booth #208. Visitors to the booth will learn more about:

NOTOCORD-hem™ - The leading software platform for the acquisition, display and analysis of physiological signals. NOTOCORD-hem supports in vivo, in vitro and ex vivo experiments and offers over 160 modules for a customized analysis.
NOTOCORD-sense –  Booth visitors will be among the first to learn about NOTOCORD-sense®, a cutting edge, Cloud-based platform for scientific collaboration. NOTOCORD-sense combines laboratory notebook features with real-time data collection, while delivering a strong platform for Data Mining by preventing the development of silos and inefficient import of raw data.
Submit™ for SEND Compliance - Instem has a wealth of experience of helping organizations to become SEND (Standard for Exchange of Nonclinical Data) enabled and its submit™ solution is the market’s most widely adopted suite of SEND software and outsourced services in 15 countries. Whether study data resides in an Instem/Notocord solution or is stored within an alternative software platform, Instem has open industry partnerships in place to ensure submit-for-SEND can provide clients with complete FDA Compliance. 

Lunchtime Mini-Course: “What’s That Elephant in the Room? SEND Submissions for Safety Pharmacology”
Sunday September 24th
12:30 – 13:30
Salon 1 Moskau

Instem will be delivering a Continuing Education course which will focus on how the CDISC SEND v3.1 standard applies to vital core battery Safety Pharmacology cardiovascular and respiratory studies, and how organizations that sponsor and/or perform these studies can prepare for its use. Instem SEND Expert, Marc Ellison, will co-chair the session and will also be available at the NOTOCORD booth on Monday September 25th to address any SEND related questions.

Poster Presentation

Additionally, during the conference NOTOCORD will co-present a poster presentation with Inria, the French National Institute for computer science and applied mathematics. The joint poster, #117, is titled "Automatic Ionic Profiling on iPSC-CM from MEA Signals Using Mathematical Modeling and Machine Learning" and will be on display from 6pm Sunday 24th September until 3:45pm Tuesday 26th September in the exhibit hall.

As in previous years NOTOCORD will be hosting an Evening Dinner cruise for its clients which takes place on Monday 25th September. 
This guided tour will take in some of Berlin’s most famous sights, including the Reichstag, Museum Island, Berlin Cathedral, the TV Tower, the Chancellery and the House of the Cultures of the World.

The Safety Pharmacology Society is a nonprofit organization that promotes knowledge, development, application, and training in Safety Pharmacology—a distinct scientific discipline that integrates the best practices of pharmacology, physiology and toxicology.

About Instem

Instem is a global provider of leading software solutions and services that are helping over 500 clients bring their life enhancing products to market faster. We enable clients in the life sciences to more efficiently collect, analyze, report and submit high quality regulatory data, while maintaining compliance for their products around the world.

Instem solutions are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making, leading to safer, more effective products.

Instem supports its global roster of clients through offices in the United States, United Kingdom, France, Japan, China and India.

Press Contacts

Julie Jones (UK HQ)
Tel: +44 (0) 1785 825600

Gary Mitchell (US HQ)
Tel: 610-941-0990